nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—Fibromyalgia—Hydrochlorothiazide—nephrolithiasis	0.0573	0.0888	CcSEcCtD
Omeprazole—Oral disorder—Hydrochlorothiazide—nephrolithiasis	0.0285	0.0441	CcSEcCtD
Omeprazole—ATP4B—Ion channel transport—CLCN5—nephrolithiasis	0.0162	0.0724	CbGpPWpGaD
Omeprazole—ATP4B—Ion channel transport—CLCN4—nephrolithiasis	0.0162	0.0724	CbGpPWpGaD
Omeprazole—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0241	CcSEcCtD
Omeprazole—Epigastric pain—Hydrochlorothiazide—nephrolithiasis	0.0149	0.023	CcSEcCtD
Omeprazole—ATP4A—Ion channel transport—CLCN5—nephrolithiasis	0.0144	0.0645	CbGpPWpGaD
Omeprazole—ATP4A—Ion channel transport—CLCN4—nephrolithiasis	0.0144	0.0645	CbGpPWpGaD
Omeprazole—CYP2C19—urine—nephrolithiasis	0.0142	0.109	CbGeAlD
Omeprazole—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0212	CcSEcCtD
Omeprazole—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0199	CcSEcCtD
Omeprazole—CYP1A2—urine—nephrolithiasis	0.0116	0.0891	CbGeAlD
Omeprazole—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0173	CcSEcCtD
Omeprazole—CYP2C9—urine—nephrolithiasis	0.011	0.0845	CbGeAlD
Omeprazole—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0165	CcSEcCtD
Omeprazole—ATP4A—renal system—nephrolithiasis	0.00998	0.0764	CbGeAlD
Omeprazole—ATP4A—kidney—nephrolithiasis	0.00965	0.0738	CbGeAlD
Omeprazole—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.00939	0.0145	CcSEcCtD
Omeprazole—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00887	0.0137	CcSEcCtD
Omeprazole—CYP3A4—urine—nephrolithiasis	0.00842	0.0645	CbGeAlD
Omeprazole—CYP2D6—urine—nephrolithiasis	0.00829	0.0634	CbGeAlD
Omeprazole—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00796	0.0123	CcSEcCtD
Omeprazole—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00775	0.012	CcSEcCtD
Omeprazole—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00732	0.0113	CcSEcCtD
Omeprazole—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00657	0.0102	CcSEcCtD
Omeprazole—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0065	0.0101	CcSEcCtD
Omeprazole—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00603	0.00933	CcSEcCtD
Omeprazole—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00594	0.0092	CcSEcCtD
Omeprazole—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00594	0.0092	CcSEcCtD
Omeprazole—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00591	0.00916	CcSEcCtD
Omeprazole—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00589	0.00912	CcSEcCtD
Omeprazole—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00583	0.00903	CcSEcCtD
Omeprazole—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00578	0.00895	CcSEcCtD
Omeprazole—Injury—Hydrochlorothiazide—nephrolithiasis	0.00568	0.00879	CcSEcCtD
Omeprazole—ATP4B—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00564	0.0252	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00564	0.0252	CbGpPWpGaD
Omeprazole—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00558	0.00864	CcSEcCtD
Omeprazole—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00555	0.0086	CcSEcCtD
Omeprazole—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00553	0.00856	CcSEcCtD
Omeprazole—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00551	0.00853	CcSEcCtD
Omeprazole—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00548	0.00849	CcSEcCtD
Omeprazole—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00548	0.00849	CcSEcCtD
Omeprazole—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00541	0.00838	CcSEcCtD
Omeprazole—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00537	0.00831	CcSEcCtD
Omeprazole—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00811	CcSEcCtD
Omeprazole—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00808	CcSEcCtD
Omeprazole—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00808	CcSEcCtD
Omeprazole—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00795	CcSEcCtD
Omeprazole—ABCC3—renal system—nephrolithiasis	0.00508	0.0389	CbGeAlD
Omeprazole—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00504	0.0078	CcSEcCtD
Omeprazole—ATP4A—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00502	0.0225	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00502	0.0225	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00502	0.0225	CbGpPWpGaD
Omeprazole—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.00498	0.0223	CbGpPWpGaD
Omeprazole—ABCC3—kidney—nephrolithiasis	0.00491	0.0376	CbGeAlD
Omeprazole—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00489	0.00757	CcSEcCtD
Omeprazole—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00478	0.00741	CcSEcCtD
Omeprazole—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00477	0.00738	CcSEcCtD
Omeprazole—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00735	CcSEcCtD
Omeprazole—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00471	0.0073	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00728	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00728	CcSEcCtD
Omeprazole—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00728	CcSEcCtD
Omeprazole—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00462	0.00715	CcSEcCtD
Omeprazole—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0046	0.00713	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0046	0.00713	CcSEcCtD
Omeprazole—ATP4B—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00459	0.0205	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00459	0.0205	CbGpPWpGaD
Omeprazole—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00454	0.00703	CcSEcCtD
Omeprazole—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00451	0.00698	CcSEcCtD
Omeprazole—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00451	0.00698	CcSEcCtD
Omeprazole—ATP4A—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00448	0.02	CbGpPWpGaD
Omeprazole—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00442	0.00685	CcSEcCtD
Omeprazole—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00439	0.0068	CcSEcCtD
Omeprazole—CYP1B1—nephron tubule—nephrolithiasis	0.00437	0.0334	CbGeAlD
Omeprazole—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00653	CcSEcCtD
Omeprazole—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00653	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00649	CcSEcCtD
Omeprazole—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00417	0.00645	CcSEcCtD
Omeprazole—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00415	0.00643	CcSEcCtD
Omeprazole—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00412	0.00637	CcSEcCtD
Omeprazole—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0041	0.00636	CcSEcCtD
Omeprazole—ATP4A—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00409	0.0183	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00409	0.0183	CbGpPWpGaD
Omeprazole—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00399	0.00617	CcSEcCtD
Omeprazole—CYP1B1—renal system—nephrolithiasis	0.00397	0.0304	CbGeAlD
Omeprazole—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00612	CcSEcCtD
Omeprazole—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00607	CcSEcCtD
Omeprazole—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00605	CcSEcCtD
Omeprazole—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00605	CcSEcCtD
Omeprazole—CYP1B1—kidney—nephrolithiasis	0.00384	0.0294	CbGeAlD
Omeprazole—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00594	CcSEcCtD
Omeprazole—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00587	CcSEcCtD
Omeprazole—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00377	0.00584	CcSEcCtD
Omeprazole—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00581	CcSEcCtD
Omeprazole—CYP1B1—cortex of kidney—nephrolithiasis	0.00374	0.0286	CbGeAlD
Omeprazole—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00367	0.00569	CcSEcCtD
Omeprazole—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00362	0.0056	CcSEcCtD
Omeprazole—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00361	0.00559	CcSEcCtD
Omeprazole—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00556	CcSEcCtD
Omeprazole—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00555	CcSEcCtD
Omeprazole—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00356	0.00551	CcSEcCtD
Omeprazole—ATP4B—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00348	0.0156	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00348	0.0156	CbGpPWpGaD
Omeprazole—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00348	0.00539	CcSEcCtD
Omeprazole—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00528	CcSEcCtD
Omeprazole—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00337	0.00521	CcSEcCtD
Omeprazole—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00519	CcSEcCtD
Omeprazole—ABCG2—nephron tubule—nephrolithiasis	0.00325	0.0249	CbGeAlD
Omeprazole—ATP4B—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00324	0.0145	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00324	0.0145	CbGpPWpGaD
Omeprazole—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00319	0.00494	CcSEcCtD
Omeprazole—CYP11A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00318	0.0142	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0031	0.0139	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0031	0.0139	CbGpPWpGaD
Omeprazole—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00479	CcSEcCtD
Omeprazole—Tension—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00477	CcSEcCtD
Omeprazole—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00476	CcSEcCtD
Omeprazole—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00473	CcSEcCtD
Omeprazole—ABCC3—NRF2 pathway—SLC2A9—nephrolithiasis	0.00305	0.0136	CbGpPWpGaD
Omeprazole—CYP2C8—renal system—nephrolithiasis	0.00304	0.0233	CbGeAlD
Omeprazole—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00471	CcSEcCtD
Omeprazole—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00468	CcSEcCtD
Omeprazole—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00459	CcSEcCtD
Omeprazole—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00294	0.00456	CcSEcCtD
Omeprazole—CYP2C8—kidney—nephrolithiasis	0.00294	0.0225	CbGeAlD
Omeprazole—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00451	CcSEcCtD
Omeprazole—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0029	0.0045	CcSEcCtD
Omeprazole—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00289	0.00447	CcSEcCtD
Omeprazole—ATP4B—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00288	0.0129	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00288	0.0129	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00288	0.0129	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00288	0.0129	CbGpPWpGaD
Omeprazole—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00445	CcSEcCtD
Omeprazole—CYP1A2—renal system—nephrolithiasis	0.00285	0.0218	CbGeAlD
Omeprazole—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00439	CcSEcCtD
Omeprazole—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00437	CcSEcCtD
Omeprazole—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00281	0.00436	CcSEcCtD
Omeprazole—CYP1A1—renal system—nephrolithiasis	0.00281	0.0215	CbGeAlD
Omeprazole—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00278	0.0043	CcSEcCtD
Omeprazole—CYP2C18—Biological oxidations—SLC26A1—nephrolithiasis	0.00275	0.0123	CbGpPWpGaD
Omeprazole—Cough—Hydrochlorothiazide—nephrolithiasis	0.00274	0.00425	CcSEcCtD
Omeprazole—CYP1A1—kidney—nephrolithiasis	0.00271	0.0208	CbGeAlD
Omeprazole—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00268	0.00414	CcSEcCtD
Omeprazole—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00268	0.00414	CcSEcCtD
Omeprazole—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00268	0.00414	CcSEcCtD
Omeprazole—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00413	CcSEcCtD
Omeprazole—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00409	CcSEcCtD
Omeprazole—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00262	0.00405	CcSEcCtD
Omeprazole—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00259	0.004	CcSEcCtD
Omeprazole—ATP4A—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00257	0.0115	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00257	0.0115	CbGpPWpGaD
Omeprazole—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00397	CcSEcCtD
Omeprazole—Shock—Hydrochlorothiazide—nephrolithiasis	0.00252	0.00391	CcSEcCtD
Omeprazole—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00389	CcSEcCtD
Omeprazole—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00388	CcSEcCtD
Omeprazole—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00384	CcSEcCtD
Omeprazole—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00379	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00362	CcSEcCtD
Omeprazole—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00232	0.00359	CcSEcCtD
Omeprazole—ATP4B—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00231	0.0103	CbGpPWpGaD
Omeprazole—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0023	0.00357	CcSEcCtD
Omeprazole—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00354	CcSEcCtD
Omeprazole—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00228	0.00353	CcSEcCtD
Omeprazole—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00226	0.0035	CcSEcCtD
Omeprazole—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00345	CcSEcCtD
Omeprazole—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00221	0.00342	CcSEcCtD
Omeprazole—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00219	0.0034	CcSEcCtD
Omeprazole—Pain—Hydrochlorothiazide—nephrolithiasis	0.00219	0.0034	CcSEcCtD
Omeprazole—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00327	CcSEcCtD
Omeprazole—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0021	0.00325	CcSEcCtD
Omeprazole—CYP3A4—renal system—nephrolithiasis	0.00206	0.0158	CbGeAlD
Omeprazole—ATP4A—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00206	0.00919	CbGpPWpGaD
Omeprazole—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00204	0.00315	CcSEcCtD
Omeprazole—CYP2D6—renal system—nephrolithiasis	0.00203	0.0155	CbGeAlD
Omeprazole—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00314	CcSEcCtD
Omeprazole—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00314	CcSEcCtD
Omeprazole—CYP1B1—Biological oxidations—SLC26A1—nephrolithiasis	0.00203	0.00906	CbGpPWpGaD
Omeprazole—CYP3A4—kidney—nephrolithiasis	0.00199	0.0152	CbGeAlD
Omeprazole—CYP2D6—kidney—nephrolithiasis	0.00196	0.015	CbGeAlD
Omeprazole—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00293	CcSEcCtD
Omeprazole—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00285	CcSEcCtD
Omeprazole—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00281	CcSEcCtD
Omeprazole—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00272	CcSEcCtD
Omeprazole—ABCC3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0017	0.0076	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0017	0.0076	CbGpPWpGaD
Omeprazole—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00263	CcSEcCtD
Omeprazole—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00252	CcSEcCtD
Omeprazole—Rash—Hydrochlorothiazide—nephrolithiasis	0.00162	0.0025	CcSEcCtD
Omeprazole—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00162	0.0025	CcSEcCtD
Omeprazole—Headache—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00249	CcSEcCtD
Omeprazole—ABCB1—nephron tubule—nephrolithiasis	0.0016	0.0123	CbGeAlD
Omeprazole—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00152	0.00236	CcSEcCtD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00152	0.00678	CbGpPWpGaD
Omeprazole—ABCB1—renal system—nephrolithiasis	0.00146	0.0112	CbGeAlD
Omeprazole—ABCB1—kidney—nephrolithiasis	0.00141	0.0108	CbGeAlD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00139	0.0062	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00139	0.0062	CbGpPWpGaD
Omeprazole—ABCB1—cortex of kidney—nephrolithiasis	0.00137	0.0105	CbGeAlD
Omeprazole—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00136	0.00608	CbGpPWpGaD
Omeprazole—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00125	0.00558	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00117	0.00524	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00117	0.00524	CbGpPWpGaD
Omeprazole—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.00114	0.00512	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00105	0.0047	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00105	0.0047	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00104	0.00467	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.00102	0.00457	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000976	0.00437	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000976	0.00437	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000956	0.00427	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000956	0.00427	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000939	0.0042	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000931	0.00417	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00087	0.00389	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00087	0.00389	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000796	0.00356	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000724	0.00324	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000724	0.00324	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—GRHPR—nephrolithiasis	0.000717	0.00321	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000696	0.00311	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000673	0.00301	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000673	0.00301	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AGXT—nephrolithiasis	0.000639	0.00286	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000634	0.00283	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000634	0.00283	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—GRHPR—nephrolithiasis	0.00062	0.00277	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000614	0.00275	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GRHPR—nephrolithiasis	0.000603	0.0027	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0006	0.00268	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0006	0.00268	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000565	0.00253	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AGXT—nephrolithiasis	0.000553	0.00247	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—APRT—nephrolithiasis	0.000543	0.00243	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—SLC26A1—nephrolithiasis	0.000543	0.00243	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AGXT—nephrolithiasis	0.000538	0.00241	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000517	0.00231	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000517	0.00231	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00048	0.00215	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—SLC26A1—nephrolithiasis	0.00047	0.0021	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—APRT—nephrolithiasis	0.00047	0.0021	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—APRT—nephrolithiasis	0.000457	0.00205	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GRHPR—nephrolithiasis	0.000457	0.00205	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—SLC26A1—nephrolithiasis	0.000457	0.00205	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000416	0.00186	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AGXT—nephrolithiasis	0.000408	0.00182	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000392	0.00175	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000392	0.00175	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AQP1—nephrolithiasis	0.000387	0.00173	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000371	0.00166	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000364	0.00163	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000364	0.00163	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CHRM3—nephrolithiasis	0.00035	0.00157	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—APRT—nephrolithiasis	0.000347	0.00155	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—SLC26A1—nephrolithiasis	0.000347	0.00155	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AQP1—nephrolithiasis	0.000335	0.0015	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AQP1—nephrolithiasis	0.000326	0.00146	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000324	0.00145	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000324	0.00145	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—APRT—nephrolithiasis	0.000315	0.00141	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000315	0.00141	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CHRM3—nephrolithiasis	0.000303	0.00136	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CHRM3—nephrolithiasis	0.000295	0.00132	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000282	0.00126	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000259	0.00116	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000258	0.00115	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000251	0.00112	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AQP1—nephrolithiasis	0.000247	0.0011	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.00023	0.00103	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.00023	0.00103	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000225	0.00101	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000225	0.001	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CHRM3—nephrolithiasis	0.000223	0.000999	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000213	0.000955	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000213	0.000955	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000212	0.000948	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.00021	0.00094	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000205	0.000919	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000203	0.000909	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000201	0.000897	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000196	0.000875	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000196	0.000875	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000189	0.000845	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000187	0.000838	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.00018	0.000803	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000175	0.000781	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000175	0.000781	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—APRT—nephrolithiasis	0.00017	0.000763	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.00017	0.000763	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000161	0.000719	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000161	0.000719	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.00016	0.000716	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000159	0.000712	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000159	0.000712	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AQP1—nephrolithiasis	0.000152	0.00068	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.000139	0.000624	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000139	0.00062	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CHRM3—nephrolithiasis	0.000138	0.000615	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000136	0.000609	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000136	0.000609	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CHRM3—nephrolithiasis	0.000126	0.000564	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.000124	0.000557	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000124	0.000553	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000121	0.000543	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000114	0.000512	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000113	0.000508	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CHRM3—nephrolithiasis	0.000113	0.000503	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.00011	0.000491	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000105	0.00047	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000105	0.00047	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000104	0.000463	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000103	0.000459	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AQP1—nephrolithiasis	9.7e-05	0.000434	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CHRM3—nephrolithiasis	8.77e-05	0.000392	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AQP1—nephrolithiasis	7.48e-05	0.000335	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CHRM3—nephrolithiasis	6.77e-05	0.000303	CbGpPWpGaD
